1,2-dipalmitoylphosphatidylcholine has been researched along with thiazolyl blue in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Manosroi, A; Manosroi, J; Peschka-Süss, R; Schubert, R; Thathang, K; Werner, RG | 1 |
| Casey, A; Chambers, G; Murphy, A; Sheehy, K | 1 |
2 other study(ies) available for 1,2-dipalmitoylphosphatidylcholine and thiazolyl blue
| Article | Year |
|---|---|
Development of highly stable and low toxic cationic liposomes for gene therapy.
Topics: 1,2-Dipalmitoylphosphatidylcholine; Animals; Cations; Cell Line, Tumor; Cell Survival; Cholesterol; Drug Compounding; Drug Stability; Excipients; Freeze Drying; Genetic Therapy; HeLa Cells; Humans; Liposomes; Mice; Quaternary Ammonium Compounds; Tetrazolium Salts; Thiazoles | 2008 |
The surfactant dipalmitoylphophatidylcholine modifies acute responses in alveolar carcinoma cells in response to low-dose silver nanoparticle exposure.
Topics: 1,2-Dipalmitoylphosphatidylcholine; Adenocarcinoma, Bronchiolo-Alveolar; Cell Line, Tumor; Cell Survival; Coloring Agents; Humans; Inflammation; Lung Neoplasms; Metal Nanoparticles; Oxazines; Reactive Oxygen Species; Silver; Tetrazolium Salts; Thiazoles; Tumor Stem Cell Assay; Xanthenes | 2015 |